Radiodermatitis, also known as radiation dermatitis, is a peculiar
symptom caused as a result of radiation therapy pertaining to the
treatment of cancerous as well as noncancerous conditions, and has
significant negative impact on a patient’s physical functionalities
and quality of life. It has been estimated that in developed
countries such as the U.S., Canada, Australia, the U.K, France, and
Germany, nearly half of the patients who receive treatment for cancer
was also subjected to radiation therapy during the illness, and about
all of them experience some degree of skin reaction. As the cases of
cancer escalates across the world, the demand in the global
radiodermatitis is expected to increment at a considerable CAGR of
3.90% during the forecast period of 2016 to 2024.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2157
This report on the global radiodermatitis market estimates the
valuation of the market to swell up to US$421.5 mn by the end of
2024, increasing from its evaluated worth of US$299.6 mn in 2015.
This report, developed by a group of professional market research
analysts, aspires to serve as a credible business tool for the
stakeholders of this market. The report studies the prospects of
various segments of the market, based on product, distribution
channel, and geography, as well as profiles a number of leading
players to understand the competitive landscape. Qualitative and
quantitative assessment of all factors that may influence the demand
for radiodermatitis has been provided in the report.
According to the International Agency for Research on Cancer (IARC),
there were 14.1 million new cases of cancer across the world, and the
figure is estimated to reach up to 21.7 million by the end of 2030.
This substantial patient volume is the primary driver of the global
radiodermatitis market. In addition to that, increasing focus on
product innovation as well as advancements in the existing products
are also expected to favor the market in the near future. Growing
number of private and public healthcare organizations, who are
constantly trying to promote the awareness regarding radiodermatitis
treatment and management, and rising number of clinical studies to
evaluate the efficiency of radiodermatitis treatment are some of the
other factors favoring the global radiodermatitis market.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2157
Based on product, the global radiodermatitis market has been
segmented into topical, oral medication, and dressings. While topical
segment is sub-segmented into hydrophilic creams, corticosteroids,
and others such as antibiotics, oral medical is further divided into
corticosteroids and others such as antibiotics and oral analgesics,
whereas dressing segment is further categorized into hydrogel, no
sting barrier film, hydrocolloid, honey impregnated gauze, silicone
coated dressing, and others such as silver leaf dressing and GM-CSF
gauze. On the basis of dressing channel, the market has been
bifurcated into hospital pharmacy, online store, and retail pharmacy
store.
Though the demand for radiodermatitis is growing in all regions
across the globe, Asia Pacific currently serves the maximum demand,
owing to higher percentage untapped patient-base. A number of
emerging economies in the Asian region are situated in tropical
region with humid weather conditions, in which the effect of
radiation dermatitis is quite high. Extensive collaborations among
the key players in order to increase their product portfolio and
involvement of well-established pharmaceutical companies in this
region on commercialization of their products are also expected to
help them increment their shares in this region.
Report Overview @
https://www.transparencymarketresearch.com/radiodermatitis-market.html
The report detects Smith & Nephew plc, 3M Healthcare, Acelity,
Convatec, Inc., and Molnlycke Health Care as the leading companies in
the global radiodermatitis market, collectively accounting for 47% of
the shares in 2015.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment